(Adnkronos Health) - "The important results of the Crossing study further support the broad potential of tezepelumab and its unique mechanism of action, which acts on TSLP at the origin of the ...
The complete positive results from the Phase III Crossing study showed that tezepelumab achieved statistically significant and clinically relevant improvements in the co-primary endpoints of ...
Beer and Tech, Inc., which operates the flower and green online store 'HitoHana', launched its Space Greening and Corporate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results